Integrating Exercise Into Personalized Ventricular Arrhythmia Risk Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy. (February 2022)

• Record Type: Journal Article
• Authors: Bosman, Laurens P.; Wang, Weijia; Lie, Øyvind H.; van Lint, Freyja H.M.; Rootwelt-Norberg, Christine; Murray, Brittney; Tichnell, Crystal; Cadrin-Tourigny, Julia; van Tintelen, J. Peter; Asselbergs, Folkert W.; Calkins, Hugh; te Riele, Anneline S.J.M.; Haugaa, Kristina H.; James, Cynthia A.
• Is Part Of: Circulation. Volume 15:Number 2(2022)
• Publication Date: 2022-02
• Subjects: arrhythmogenic right ventricular dysplasia -- exercise -- prognosis; Arrhythmia -- Periodicals; Heart -- Electric properties -- Periodicals; 616.128
• DOI: 10.1161/CIRCEP.121.010221
• Languages: English
• ISSNs: 1941-3149

Abstract

Abstract : Background: Exercise is associated with sustained ventricular arrhythmias (VA) in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) but is not included in the ARVC risk calculator (arvcrisk.com ). The objective of this study is to quantify the influence of exercise at diagnosis on incident VA risk and evaluate whether the risk calculator needs adjustment for exercise. Methods: We interviewed ARVC patients without sustained VA at diagnosis about their exercise history. The relationship between exercise dose 3 years preceding diagnosis (average METh/wk) and incident VA during follow-up was analyzed with time-to-event analysis. The incremental prognostic value of exercise to the risk calculator was evaluated by Cox models. Results: We included 176 patients (male, 43.2%; age, 37.6±16.1 years) from 3 ARVC centers, of whom 53 (30.1%) developed sustained VA during 5.4 (2.7–9.7) years of follow-up. Exercise at diagnosis showed a dose-dependent nonlinear relationship with VA, with no significant risk increase <15 to 30 METh/wk. Athlete status, using 3 definitions from literature (>18, >24, and >36 METh/wk), was significantly associated with VA (hazard ratios, 2.53–2.91) but was also correlated with risk factors currently in the risk calculator model. Thus, adding athlete status to the model did not change the C index of 0.77 (0.71–0.84) and showed no significant improvement (Akaike information criterion change, <2). Conclusions: Exercise at diagnosis was dose dependently associated with risk of sustained VA in ARVC patients but only above 15 to 30 METh/wk. Exercise does not appear to have incremental prognostic value over the risk calculator. The ARVC risk calculator can be used accurately in athletic patients without modification. Abstract : Supplemental Digital Content is available in the text.